Accueil・Liste d'Actions・Design Therapeutics Inc

Design Therapeutics Inc

Fermé

11.85 0.94

Acheter Vendre

Résumé

Variation du prix de l'action

24h

Actuel

Min

11.67

Max

11.8

Chiffres clés
By Trading Economics
Revenu	-1.6M -18M
BPA	-0.29
Employés	54
EBITDA	534K -17M

Recommandations
By TipRanks
Recommandations	Achat Fort
Prévisions sur 12 Mois	+76.15% upside

Dividendes
By Acuity
Prochains Résultats	5 août 2026

Statistiques du Marché
By TradingEconomics
Capitalisation Boursière	-59M 741M
Ouverture précédente	10.91
Clôture précédente	11.85

Design Therapeutics Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

26 juil. 2026, 23:56 UTC

Cryptocurrency values rise as global equity markets approach $166 trillion amid mixed sentiment and geopolitical uncertainties.

26 juil. 2026, 23:56 UTC

"Ethereum and Bitcoin rise amid mixed market sentiment as Japan shifts to expansionary fiscal policy and key economic data looms."

26 juil. 2026, 23:56 UTC

"Ethereum Rises 4.2% Amidst Strong Global Equity Markets and Upcoming Key Economic Data Releases."

26 juil. 2026, 23:56 UTC

Cryptocurrency gains amid cautious investor sentiment in global equities as markets brace for key economic data and Fed interest rate decision.

26 juil. 2026, 23:52 UTC

Australia's RBA Trimmed Mean CPI Release on July 29, 2026, Expected to Impact Monetary Policy Amid Rising Trade Tensions and Cost-of-Living Concerns.

26 juil. 2026, 23:52 UTC

Australia's Inflation Rate YoY Data Set for Release on July 29, 2026, with Forecasted Increase to 4.1%, Impacting Monetary Policy and Market Sentiment.

26 juil. 2026, 23:51 UTC

Correlated Moves

EUR/CAD shows a slight increase in after-hours trading, reflecting volatility and aligning with a similar uptick in EUR/USD amid comparable macroeconomic factors.

26 juil. 2026, 23:51 UTC

EUR/SEK shows notable weakness in after-hours trading, declining since Friday's close and reaching a session low amid unusual downward pressure.

26 juil. 2026, 23:51 UTC

Macro News

Correlated Moves

Bitcoin prices have risen to $65,392, reflecting optimism amid speculation of reaching $180,000. Trade tensions could impact global markets, including cryptocurrencies.

26 juil. 2026, 23:41 UTC

GBP/CAD advances slightly in after-hours trading, positioned near the lower end of its one-month range. No specific news was identified for the move.

26 juil. 2026, 23:41 UTC

Upcoming U.S. Employment Cost Index report on July 31 to reveal key wage growth data amid rising inflation and consumer concerns over grocery prices.

26 juil. 2026, 23:41 UTC

Employment Cost Index for Q2 2026 set to rise by 0.8%, signaling potential implications for inflation and Federal Reserve interest rate decisions.

26 juil. 2026, 23:41 UTC

U.S. Employment Cost Index Benefits Data Set for Release on July 31, 2026, Amid Global Labor Market Dynamics and Inflation Concerns.

26 juil. 2026, 23:41 UTC

Canada's preliminary monthly GDP report on July 31, 2026, is anticipated to reveal growth amid mixed economic signals and external risks.

26 juil. 2026, 23:23 UTC

Upcoming PCE Price Index Release on July 30, 2026, Expected to Reflect Consumer Inflation Amid Rising Grocery Prices and Economic Pressures.

26 juil. 2026, 23:23 UTC

U.S. PCE Price Index Expected to Rise 0.4% in June Amid Ongoing Inflation Concerns and Consumer Behavior Shifts

26 juil. 2026, 23:23 UTC

U.S. Personal Spending MoM Data Release on July 30, 2026 Expected to Show 0.4% Growth Amid Rising Grocery Prices and Changing Consumer Habits.

26 juil. 2026, 23:23 UTC

Core PCE Price Index MoM for June 2026 set to release on July 30, with a modest forecasted increase of 0.1%, as markets remain cautiously optimistic amid mixed equity performance and Fed policy discussions.

26 juil. 2026, 23:23 UTC

US Personal Income MoM Data Release on July 30, 2026 Expected to Show Modest 0.3% Increase Amid Mixed Economic Signals

26 juil. 2026, 23:23 UTC

U.S. GDP Price Index Forecasted to Rise 3.7% Amid Inflation Concerns Ahead of July Release

26 juil. 2026, 23:23 UTC

U.S. Q2 2026 GDP Growth Rate Release Forecasts 2.3% Amid Cautious Market Sentiment and Rising Consumer Prices

26 juil. 2026, 23:23 UTC

South Korea's July export growth expected to remain strong at 70.9% YoY amid market volatility and global uncertainties, with a report due August 1, 2026.

26 juil. 2026, 23:13 UTC

South Africa's upcoming balance of trade data on July 31, 2026, is crucial as it follows a surprising May deficit amid rising imports and declining exports.

26 juil. 2026, 23:13 UTC

S&P/Case-Shiller Home Price Index Expected to Show Modest 0.8% YoY Growth Amid Cooling U.S. Housing Market and High Inflation Concerns

26 juil. 2026, 23:11 UTC

Correlated Moves

News

Ethereum is rising during Sunday’s trading session, gaining alongside Bitcoin amid strong market activity and global developments influencing investor sentiment.

26 juil. 2026, 23:11 UTC

Correlated Moves

News

Ethereum is advancing during Sunday’s session, supported by Bitcoin's upward movement. The asset is trading well above recent averages amid strong market activity.

26 juil. 2026, 23:02 UTC

After-market trading for SGD/CHF shows an upward trend, gaining since Friday's close. It is currently 1.09% above its 20-day moving average.

26 juil. 2026, 23:01 UTC

GBP/CHF moved higher during after-market hours, reflecting strong momentum near the upper end of its one-month range. No specific news was identified.

26 juil. 2026, 23:01 UTC

Correlated Moves

GBP/HKD is trading higher in after-market hours, reflecting a cumulative return that peaked at 0.30%. The pair shows unusual strength amid recent EUR/USD gains.

26 juil. 2026, 23:01 UTC

Brazil's Unemployment Rate Release on July 30 Expected to Show Continued Improvement Amid Economic Optimism and External Challenges.

Comparaison

Variation de prix

Design Therapeutics Inc prévision

Objectif de Prix

By TipRanks

76.15% hausse

Prévisions sur 12 Mois

Moyen 20.75 USD 76.15%

Haut 22 USD

Bas 20 USD

Basé sur 5 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

5 ratings

Achat

Maintien

Vente

Basé sur 5 qui ont noté l'action Microsoft Corp. au cours des 3 derniers mois.

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

À Propos Design Therapeutics Inc

Design Therapeutics, Inc. a biopharmaceutical company, researches, designs, develops, and commercializes small molecule therapeutic drugs for the treatment of genetic diseases in the United States. The company utilizes its GeneTAC platform to design and develop therapeutic candidates for inherited diseases caused by nucleotide repeat expansion. Its lead product candidates for potentially disease-modifying treatment comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ systems dependent on mitochondrial function that brings to neurological, cardiac, and metabolic dysfunction; Myotonic Dystrophy Type-1, a dominantly-inherited, monogenic progressive neuromuscular disease affecting skeletal muscle, heart, brain, and other organs; Fuchs Endothelial Corneal Dystrophy, a genetic eye disease characterized by bilateral degeneration of corneal endothelial cells and progressive loss of vision; and Huntington's Disease, a dominantly inherited, monogenic neurodegenerative disease characterized by movement, cognitive, and psychiatric disorders. Design Therapeutics, Inc. was incorporated in 2017 and is headquartered in Carlsbad, California.